:775-784

Author(s): Antonescu, C.R., et al. “ Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma.” Genes Chromosomes Cancer. 52.8

Abstract

Conventional epithelioid hemangioendotheliomas (EHE) have a distinctive morphologic appearance and are characterized by a recurrent t(1;3) translocation, resulting in a WWTR1-CAMTA1 fusion gene. We have recently encountered a fusion-negative subset characterized by a somewhat different morphology, including focally well-formed vasoformative features, which was further investigated for recurrent genetic abnormalities. Based on a case showing strong transcription factor E3 (TFE3) immunoreactivity, fluorescence in situ hybridization (FISH) analysis for TFE3 gene rearrangement was applied to the index case as well as to nine additional cases, selected through negative WWTR1-CAMTA1 screening. A control group, including 18 epithelioid hemangiomas, nine pseudomyogenic HE, and three epithelioid angiosarcomas, was also tested. TFE3 gene rearrangement was identified in 10 patients, with equal gender distribution and a mean age of 30 years old. The lesions were located in somatic soft tissue in six cases, lung in three and one in bone. One case with available frozen tissue was tested by RNA sequencing and FusionSeq data analysis to detect novel fusions. A YAP1-TFE3 fusion was thus detected, which was further validated by FISH and reverse transcription polymerase chain reaction (RT-PCR). YAP1 gene rearrangements were then confirmed in seven of the remaining nine TFE3-rearranged EHEs by FISH. No TFE3 structural abnormalities were detected in any of the controls. The TFE3-rearranged EHEs showed similar morphologic features with at least focally, well-formed vascular channels, in addition to a variably solid architecture. All tumors expressed endothelial markers, as well as strong nuclear TFE3. In summary, we are reporting a novel subset of EHE occurring in young adults, showing a distinct phenotype and YAP1-TFE3 fusions. © 2013 Wiley Periodicals, Inc.

Similar Articles

:303-30

Author(s): Liu, Y.I., et al. “Hepatic epithelioid hemangioendothelioma.” Dig Dis Sci. 56.2

:61-65

Author(s): Kim, S.G., et al. “A case of primary hepatic epithelioid hemangioendothelioma mimicking metastatic carcinoma.” Korean J Gastroenterol. 50.1

, et al

Author(s): Mertens, F

:89-91

Author(s): Mukherjee, S., et al. “Hemangioendothelioma of soft tissue: Cytological dilemma in two unusual sites.” J Cytol. 29

:281-285

Author(s): Radzikowska, E., et al. “Pulmonary epithelioid hemangioendothelioma - interferon 2-alpha treatment- Case Report.” Pneumol Allergol Pol. 76.4

:866-873

Author(s): Gordillo, G.M., et al. “A key angiogenic role of monocyte chemoattractant protein-1 in hemangioendothelioma proliferation.” Am J Physiol Cell Physiol. 4.C

:116-121

Author(s): Budousquie, A.C., et al. “Complex translocation (7;22) identified in an epithelioid hemangioendothelioma.” Cancer Genet Cytogenet. 92

:4006-4012

Author(s): Mascarelli, P.E., et al. “Bartonella species bacteremia in two patients with epithelioid hemangioendothelioma.” J Clin Microbiol. 49

:1312-1318

Author(s): Lau, K., et al. “Clinical patterns and outcome in epithelioid hemangioendothelioma with or without pulmonary involvement.” Chest. 140

:43-4

Author(s): Gomez-Arellano, L.I., et al. “Multicentric epithelioid hemangioendothelioma of bone. Report of a case with radiologic-pathologic correlation.”Annals Diagn Pathol. 16

:e10

Author(s): Pommaret, E., et al. Colonic metastases of an epithelioid hemangioendothelioma: an unusual cause of periumbilical pain and wheight loss.” Dig Liver Dis. 43.5

:2010-2013

Author(s): Bagan, P., et al. “Prognostic factors and surgical indications of pulmonary epithelioid hemangioendothelioma: A review of the literature.” Ann Thorac Surg. 82.6

:1480-1481

Author(s): Kim, S.J., & Kim, Y.C. “Unusual extrahepatic metastasis to the soft tissue of the left cervical neck area from hepatic epithelioid hemangioendothelioma.” Hepatology. 54.4

:120

Author(s): Gherman,C.D., & Fodor, D. “Epithelioid hemangioendothelioma of the forearm with radius involvement: Case report.” Diagn Pathol. 6

:265-27

Author(s): Larochelle, O., et al. “Best Cases from the AFIP- Epithelioid hemangioendothelioma of bone.” Radio Graphics. 26.1

:789-792

Author(s): Rest, C.C., et al. “FDG PET in epithelioid hemangioendothelioma.” Clin Nucl Med. 29.12

:739-746

Author(s): Murali, R., et al. Cytologic features of epithelioid hemangioendothelioma.”Am J Clin Pathol. 136.5

:220

Author(s): Teo, S.K., et al. “Intravascular bronchioloalveolar tumor: a 20 year survival.” Med J Aust. 142

M

Author(s): Christopher, D

:1616-1619

Author(s): Van, K.M.E.E., et al. “Epithelioid hemangioendothelioma of the lung: clinical and pathological pitfalls.” Eur Respir J. 8

:237-23

Author(s): Pinet, C., et al. “Aggressive form of pleural epithelioid hemangioendothelioma: complete response after chemotherapy.” Eur Respir J. 14.1

:133-136

Author(s): Gaur, S., et al. “Activity of angiogenesis inhibitors in metastatic epithelioid hemangioendothelioma: A case report.” Cancer Biol Med. 9.1

: 46920

Author(s): Drazin, D., et al. “Epithelioid hemangioendothelioma of the mastoid: resection for recurrence and adjuvant radiation with 8-year follow up.” Case Rep Surg.2013